Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03480893

Ligand	Ligand name	Chain	PDB	Tanimoto
803	LOVASTATIN	A,B	1CQP	0.73
ZBA	12,13-Epoxytrichothec-9-ene-3,4,8,15-tetrol-4,15-diacetate-8-isovalerate	A	2RKV	0.71
ZBA	12,13-Epoxytrichothec-9-ene-3,4,8,15-tetrol-4,15-diacetate-8-isovalerate	A,B,C,D	2ZBA	0.71
TH2	TESTOSTERONE HEMISUCCINATE	A,B	2CBT	0.73
TH2	TESTOSTERONE HEMISUCCINATE	A,B,C,D,E,F	2CBQ	0.73
TH2	TESTOSTERONE HEMISUCCINATE	A	2CBO	0.73
VD2	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYL-CYCLOHEXANE-1,3-DIOL	A	1RKH	0.72
KH1	5-(2-{1-[1-(4-ETHYL-4-HYDROXY-HEXYLOXY)-ETHYL]-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE}-ETHYLIDENE)-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1IE8	0.73
0AS	asiatic acid	A	2QN1	0.73
COV	(1S,3R,5Z,7E,14beta,17alpha)-17-[(2S,4S)-4-(2-hydroxy-2-methylpropyl)-2-methyltetrahydrofuran-2-yl]-9,10-secoandrosta-5,7,10-triene-1,3-diol	A	3CS4	0.7
SIM	SIMVASTATIN	A,B,C,D	1HW9	0.75
SIH	PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE	H	1DBM	0.71
PGX	7-[6-(3-HYDROPEROXY-OCT-1-ENYL)-2,3-DIOXA-BICYCLO[2.2.1]HEPT-5-YL]-HEPT-5-ENOIC ACID	A,B,C,D	1DDX	0.82
2OB	CHOLESTERYL OLEATE	A	2OBD	0.71
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.71
DOG	DIGOXIGENIN	A	1LKE	0.71
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A,B,E	1R8Q	0.78
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A	1RE0	0.78
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A,E	1S9D	0.78
O1C	2ALPHA-(3-HYDROXYPROPYL)-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HB7	0.71
JC1	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2S,3S)-3-(2-hydroxyethyl)heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol	A	2ZXN	0.71
CLL	CHOLESTERYL LINOLEATE	A,B	1CLE	0.71
PIE	1,2-DIACYL-SN-GLYCERO-3-PHOSPHOINOSITOL	A,B,C,D	1UW5	0.72
PIE	1,2-DIACYL-SN-GLYCERO-3-PHOSPHOINOSITOL	A,C,D,E	1KB9	0.72
MVB	(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL	A,B,C	1YA8	0.72
PT5	(1S)-2-{[(R)-hydroxy{[(1R,2R,3S,4R,5R,6S)-2,3,6-trihydroxy-4,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}-1-[(octadecanoyloxy)methyl]ethyl (8E,11E)-icosa-5,8,11,14-tetraenoate	A	3GPE	0.7
OLC	(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate	A	3D4S	0.73
GMM	GLUCOSE MONOMYCOLATE	A	1UQS	0.76
LVA	(3R,5R)-7-((1R,2R,6S,8R,8AS)-2,6-DIMETHYL-8-{[(2R)-2-METHYLBUTANOYL]OXY}-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)-3,5-DIHYDROXYHEPTANOIC ACID	A,B	1T02	0.77
114	COMPACTIN	A,B,C,D	1HW8	0.77
FUA	FUSIDIC ACID	A	1QCA	0.75
FUA	FUSIDIC ACID	A,B,C,D,E,F,G,H,I,J,K,L	1Q23	0.75
FUA	FUSIDIC ACID	A,B	2VUF	0.75
RCL	RICINOLEIC ACID	A	2CM4	0.72
RCL	RICINOLEIC ACID	A	2CM9	0.72
RCL	RICINOLEIC ACID	A	1FK7	0.72
0MA	maslinic acid	A	2QN2	0.71
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.7
0CO	(1S,3R,5Z,7E,14beta,17alpha,23R)-23-(2-hydroxy-2-methylpropyl)-20,24-epoxy-9,10-secochola-5,7,10-triene-1,3-diol	A	3CS6	0.7
VDZ	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1RJK	0.7
8PG	(8S,12S)-15S-HYDROXY-9-OXOPROSTA-10Z,13E-DIEN-1-OIC ACID	A,B	2G5W	0.77
MVD	2ALPHA-METHYL-1ALPHA,25-DIHYDROXY-VITAMIN D3	A	2HB8	0.7
E4H	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2HFK	0.73
OPD	9R,13R-12-OXOPHYTODIENOIC ACID	A,B	1ICQ	0.72
MRC	MUPIROCIN	A	1JZS	0.72
MRC	MUPIROCIN	A,T	1FFY	0.72
MRC	MUPIROCIN	A	1QU3	0.72
MRC	MUPIROCIN	A,T	1QU2	0.72
JB1	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,3S)-3-(2-hydroxyethyl)heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol	A	2ZXM	0.71
C33	2ALPHA-PROPYL-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAM	0.7
PG2	PROSTAGLANDIN D2	A,B	1RY0	0.78
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A	2ZB4	0.74
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A,B	1V3V	0.74
BIV	21-NOR-9,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1,3,25-TRIOL, 20-(4-HYDROXY-4-METHYLPENTYL)-, (1A,3B,5Z,7E)	A	2HCD	0.71
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2ZBZ	0.7
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1RK3	0.7
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1DB1	0.7
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1IE9	0.7
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2HC4	0.7
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2ZLC	0.7
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	3CV9	0.7
B7N	(1R)-2-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}-1-[(octadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate	A	3B7N	0.72
B7N	(1R)-2-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}-1-[(octadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate	A	3B7Z	0.72
FUG	FUMAGILLIN	A,B	3FMQ	0.72
FUG	FUMAGILLIN	A	1BOA	0.72
NTH	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	A,B	1BUQ	0.71